Diosmin ameliorates renal fibrosis through inhibition of inflammation by regulating SIRT3-mediated NF-κB p65 nuclear translocation

被引:11
|
作者
Zhao, Wen-Man [1 ,2 ]
Li, Xun-Liang [1 ,2 ]
Zhu, Yuyu [1 ,2 ]
Shi, Rui [1 ,2 ]
Wang, Zhi-Juan [1 ,2 ]
Xiao, Jian-Ping [1 ,2 ]
Wang, De-Guang [1 ,2 ]
机构
[1] Anhui Med Univ, Affiliated Hosp 2, Dept Nephrol, 678 Furong Rd, Hefei 230601, Anhui, Peoples R China
[2] Anhui Med Univ, Affiliated Hosp 2, Inst Kidney Dis Inflammat & Immun Mediated Dis, Hefei, Peoples R China
关键词
Diosmin; Fibrosis; Inflammation; NF-kappa B p65; UUO; SIRT3; INDUCED HEPATIC-FIBROSIS; KIDNEY-DISEASE; TGF-BETA/SMAD; BETA; PROTECTS; INJURY;
D O I
10.1186/s12906-023-04330-z
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background Renal fibrosis is considered an irreversible pathological process and the ultimate common pathway for the development of all types of chronic kidney diseases and renal failure. Diosmin is a natural flavonoid glycoside that has antioxidant, anti-inflammatory, and antifibrotic activities. However, whether Diosmin protects kidneys by inhibiting renal fibrosis is unknown. We aimed to investigate the role of Diosmin in renal interstitial fibrosis and to explore the underlying mechanisms.Methods The UUO mouse model was established and gavaged with Diosmin (50 mg/kg center dot d and 100 mg/kg center dot d) for 14 days. HE staining, Masson staining, immunohistochemistry, western blotting and PCR were used to assess renal tissue injury and fibrosis. Elisa kits were used to detect the expression levels of IL-1 beta, IL-6, and TNF-alpha and the activity of SIRT3 in renal tissues. In addition, enrichment maps of RNA sequencing analyzed changes in signaling pathways. In vitro, human renal tubular epithelial cells (HK-2) were stimulated with TGF-beta 1 and then treated with diosmin (75 mu M). The protein and mRNA expression levels of SIRT3 were detected in the cells. In addition, 3-TYP (selective inhibitor of SIRT3) and SIRT3 small interfering RNA (siRNA) were used to reduce SIRT3 levels in HK-2.Results Diosmin attenuated UUO-induced renal fibrosis and TGF-beta 1-induced HK-2 fibrosis. In addition, Diosmin reduced IL-1 beta, IL-6, and TNF-alpha levels in kidney tissues and supernatants of HK-2 medium. Interestingly, Diosmin administration increased the enzymatic activity of SIRT3 in UUO kidneys. In addition, Diosmin significantly increased mRNA and protein expression of SIRT3 in vitro and in vivo. Inhibition of SIRT3 expression using 3-TYP or SIRT3 siRNA abolished the anti-inflammatory effects of diosmin in HK-2 cells. Enrichment map analysis by RNA sequencing indicates that the nuclear factor-kappa B (NF-kappa B) signaling pathway was inhibited in the Diosmin intervention group. Furthermore, we found that TGF-beta 1 increased the nuclear expression of nuclear NF-kappa B p65 but had little significant effect on the total intracellular expression of NF-kappa B p65. Additionally, Diosmin reduced TGF-beta 1-caused NF-kappa B p65 nuclear translocation. Knockdown of SIRT3 expression by SIRT3 siRNA increased the nuclear expression of NF-kappa B p65 and abolished the inhibition effect of Diosmin in NF-kappa B p65 expression.Conclusions Diosmin reduces renal inflammation and fibrosis, which is contributed by inhibiting nuclear translocation of NF-kappa B P65 through activating SIRT3.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Linarin suppresses glioma through inhibition of NF-κB/p65 and up-regulating p53 expression in vitro and in vivo
    Zhen, Zi-Gang
    Ren, Shao-Hua
    Ji, Hong-Ming
    Ma, Jiu-Hong
    Ding, Xin-Min
    Feng, Fu-Qiang
    Chen, Shing-Li
    Zou, Peng
    Ren, Jin-Rui
    Jia, Lu
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 95 : 363 - 374
  • [22] Fas-associated factor-1 inhibits nuclear factor-κB (NF-κB) activity by interfering with nuclear translocation of the RelA (p65) subunit of NF-κB
    Park, MY
    Jang, HD
    Lee, SY
    Lee, KJ
    Kim, E
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (04) : 2544 - 2549
  • [23] Nuclear translocation of the p65 subunit of NF-κB in L5178Y sublines differing in antioxidant defense
    B. Sochanowicz
    I. Szumiel
    I. Grądzka
    Radiation and Environmental Biophysics, 1999, 38 : 125 - 131
  • [24] Nuclear translocation of the p65 subunit of NF-κB in L5178Y sublines differing in antioxidant defense
    Sochanowicz, B
    Szumiel, I
    Gradzka, I
    RADIATION AND ENVIRONMENTAL BIOPHYSICS, 1999, 38 (02) : 125 - 131
  • [25] The proapoptotic effects of sulindac, sulindac sulfone and indomethacin are mediated by nucleolar translocation of the RelA(p65) subunit of NF-κB
    C J Loveridge
    A D H MacDonald
    H C Thoms
    M G Dunlop
    L A Stark
    Oncogene, 2008, 27 : 2648 - 2655
  • [26] The proapoptotic effects of sulindac, sulindac sulfone and indomethacin are mediated by nucleolar translocation of the RelA(p65) subunit of NF-κB
    Loveridge, C. J.
    MacDonald, A. D. H.
    Thoms, H. C.
    Dunlop, M. G.
    Stark, L. A.
    ONCOGENE, 2008, 27 (18) : 2648 - 2655
  • [27] Inhibition of Nuclear Transport of NF-κB p65 by the Salmonella Type III Secretion System Effector SpvD
    Rolhion, Nathalie
    Furniss, R. Christopher D.
    Grabe, Grzegorz
    Ryan, Aindrias
    Liu, Mei
    Matthews, Sophie A.
    Holden, David W.
    PLOS PATHOGENS, 2016, 12 (05)
  • [28] Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK/NF-κB/p65 regulatory axis
    Qiulun Lu
    Zejun Ma
    Ye Ding
    Tatiana Bedarida
    Liming Chen
    Zhonglin Xie
    Ping Song
    Ming-Hui Zou
    Nature Communications, 10
  • [29] Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK/NF-κB/p65 regulatory axis
    Lu, Qiulun
    Ma, Zejun
    Ding, Ye
    Bedarida, Tatiana
    Chen, Liming
    Xie, Zhonglin
    Song, Ping
    Zou, Ming-Hui
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [30] Ubiquitin-Fold Modifier-I Participates in the Diabetic Inflammatory Response by Regulating NF-κB p65 Nuclear Translocation and the Ubiquitination and Degradation of IκBα
    Hu, Xiaolei
    Zhang, Hengyan
    Zhuang, Langen
    Jin, Guoxi
    Yang, Qingqing
    Li, Min
    Sun, Weihua
    Chen, Fengling
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 795 - 809